Cleared Traditional

K021445 - ETEST CEFDITOREN FOR S. PNEUMONIAE AND ...

K021445 is the FDA 510(k) clearance for ETEST CEFDITOREN FOR S. PNEUMONIAE AND ... by Ab Biodisk. It is a Class 2 Microbiology device (product code JWY) cleared through the Traditional 510(k) pathway after a 31-day FDA review.

K021445 · Ab Biodisk · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2002
Decision
31d
Days
Class 2
Risk

K021445 is an FDA 510(k) clearance for the ETEST CEFDITOREN FOR S. PNEUMONIAE AND H. INFLUENZAE. Classified as Manual Antimicrobial Susceptibility Test Systems (product code JWY), Class II - Special Controls.

Submitted by Ab Biodisk (Solna, SE). The FDA issued a Cleared decision on June 6, 2002 after a review of 31 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ab Biodisk devices

Submission Details

510(k) Number K021445 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 06, 2002
Decision Date June 06, 2002
Days to Decision 31 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 102d · This submission: 31d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JWY Manual Antimicrobial Susceptibility Test Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JWY Manual Antimicrobial Susceptibility Test Systems

All 360
Devices cleared under the same product code (JWY) and FDA review panel - the closest regulatory comparables to K021445.
MICROSCAN MICROSTREP PLUS PANEL NEW ANTIMICROBIAL- CEFTRIAXONE
K021110 · Dade Microscan, Inc. · Jun 2002
MICROSTREP PLUS PANEL, AZITHROMYCIN
K021169 · Dade Microscan, Inc. · Jun 2002
MICROSCAN MICROSTREP PLUS PANEL NEW ANTIMICROBIAL-CEFEPIME
K021188 · Dade Microscan, Inc. · Jun 2002
MICROSCAN MICROSTREP PLUS PANEL-MEROPENEM
K020938 · Dade Microscan, Inc. · Jun 2002
CEFOTAXIME
K020859 · Trek Diagnostic Systems, Inc. · May 2002
GATIFLOXIN
K020762 · Trek Diagnostic Systems, Inc. · May 2002